Literature DB >> 9710216

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.

D Pende1, L Accame, L Pareti, A Mazzocchi, A Moretta, G Parmiani, L Moretta.   

Abstract

NK cells selectively lyse tumor cells which do not express one or more MHC class I alleles. The ability to discriminate between self normal or tumor cells is due to the expression of MHC class I-specific killer inhibitory receptors (KIR). In the present study we analyzed melanoma cell lines which were highly susceptible to NK cell-mediated lysis in spite of the expression of a complete set of HLA class I alleles. Quantitative analysis of the HLA class I expression using allele-specific monoclonal antibodies (mAb) revealed a down-regulation of all HLA class I molecules. Treatment of melanoma cells with IFN-gamma resulted in up-regulation of all HLA class I alleles that was paralleled by the acquisition of resistance to lysis. That resistance to lysis reflected the up-regulation of HLA class I molecules was revealed by the finding that mAb-mediated masking of either KIR or their HLA class I ligands completely restored the melanoma cell lysis. These results were obtained by the use of selected NK cell clones derived either from allogeneic or autologous donors. In addition, similar results were obtained using in vitro expanded autologous NK cell populations. Our data indicate that NK cells can lyse not only melanoma cells which have lost the expression of one or more HLA class I alleles but also cells expressing a decreased amount of class I molecules.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710216     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC).

Authors:  K J Palmer; M Harries; M E Gore; M K Collins
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.

Authors:  D Fruci; M Benevolo; L Cifaldi; S Lorenzi; E Lo Monaco; E Tremante; P Giacomini
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

3.  Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.

Authors:  Paolo Carrega; Gaetana Pezzino; Paola Queirolo; Irene Bonaccorsi; Michela Falco; Giuseppe Vita; Daniela Pende; Aldo Misefari; Alessandro Moretta; Maria Cristina Mingari; Lorenzo Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

4.  KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.

Authors:  José A Campillo; Isabel Legaz; M Rocío López-Álvarez; José Miguel Bolarín; Beatriz Las Heras; Manuel Muro; Alfredo Minguela; María R Moya-Quiles; Rosa Blanco-García; Helios Martínez-Banaclocha; Ana M García-Alonso; M Rocío Alvarez-López; Jorge A Martínez-Escribano
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

5.  Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.

Authors:  D Pende; S Parolini; A Pessino; S Sivori; R Augugliaro; L Morelli; E Marcenaro; L Accame; A Malaspina; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

6.  In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

Authors:  D E Speiser; M J Pittet; D Valmori; R Dunbar; D Rimoldi; D Liénard; H R MacDonald; J C Cerottini; V Cerundolo; P Romero
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

7.  Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.

Authors:  Marco Fangazio; Erik Ladewig; Karen Gomez; Laura Garcia-Ibanez; Rahul Kumar; Julie Teruya-Feldstein; Davide Rossi; Ioan Filip; Qiang Pan-Hammarström; Giorgio Inghirami; Renzo Boldorini; German Ott; Annette M Staiger; Björn Chapuy; Gianluca Gaidano; Govind Bhagat; Katia Basso; Raul Rabadan; Laura Pasqualucci; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.